Immunocore Holdings plc (IMCR) Social Stream
IMMUNOCORE HOLDINGS PLC (IMCR) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering IMCR.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-07 | 3 | $65 | $53 | $58 | $73.79 | -21.4% |
| 2022-01-26 | 3 | $56 | $45 | $51.333 | $73.79 | -30.43% |
| 2022-03-10 | 3 | $80 | $45 | $58.5 | $73.79 | -20.72% |
| 2022-03-30 | 4 | $80 | $45 | $58.25 | $73.79 | -21.06% |
| 2022-05-11 | 4 | $80 | $45 | $58.5 | $73.79 | -20.72% |
| 2022-05-18 | 4 | $80 | $45 | $59 | $73.79 | -20.04% |
| 2022-07-13 | 4 | $80 | $50 | $60.25 | $73.79 | -18.35% |
| 2022-08-02 | 5 | $85 | $50 | $65.2 | $73.79 | -11.64% |
| 2022-08-09 | 6 | $85 | $50 | $66 | $73.79 | -10.56% |
| 2022-08-11 | 6 | $85 | $55 | $70.666 | $73.79 | -4.23% |
| 2022-09-05 | 6 | $85 | $60 | $73 | $73.79 | -1.07% |
| 2022-09-14 | 8 | $85 | $65 | $75.5 | $73.79 | 2.32% |
| 2022-10-12 | 8 | $85 | $65 | $74.875 | $73.79 | 1.47% |
| 2022-11-10 | 8 | $85 | $65 | $75.75 | $73.79 | 2.66% |
| 2022-11-21 | 8 | $90 | $65 | $77.625 | $73.79 | 5.2% |
| 2022-11-22 | 8 | $90 | $65 | $77.375 | $73.79 | 4.86% |
| 2022-12-12 | 9 | $90 | $65 | $77.666 | $73.79 | 5.25% |
| 2022-12-19 | 10 | $90 | $65 | $77.9 | $73.79 | 5.57% |
| 2023-02-03 | 10 | $90 | $65 | $78.5 | $73.79 | 6.38% |
| 2023-03-08 | 10 | $90 | $65 | $79.2 | $73.79 | 7.33% |
| 2023-03-13 | 10 | $90 | $63 | $79 | $73.79 | 7.06% |
| 2023-04-25 | 11 | $90 | $63 | $78.181 | $73.79 | 5.95% |
| 2023-05-10 | 12 | $90 | $63 | $78.75 | $73.79 | 6.72% |
| 2023-05-22 | 11 | $90 | $72 | $80.545 | $73.79 | 9.15% |
| 2023-07-11 | 11 | $90 | $72 | $80.454 | $73.79 | 9.03% |
| 2023-07-20 | 12 | $90 | $67 | $79.333 | $73.79 | 7.51% |
| 2023-08-02 | 12 | $90 | $67 | $78.818 | $73.79 | 6.81% |
| 2023-08-10 | 12 | $90 | $67 | $79.636 | $73.79 | 7.92% |
| 2023-08-11 | 12 | $91 | $67 | $80.583 | $73.79 | 9.21% |
| 2023-08-16 | 13 | $91 | $67 | $80.846 | $73.79 | 9.56% |
| 2023-09-13 | 15 | $91 | $67 | $80.428 | $73.79 | 9% |
| 2023-10-26 | 15 | $91 | $67 | $81.142 | $73.79 | 9.96% |
| 2023-10-31 | 16 | $91 | $67 | $81.333 | $73.79 | 10.22% |
| 2023-11-08 | 17 | $91 | $67 | $81.333 | $73.79 | 10.22% |
| 2023-11-13 | 17 | $92 | $67 | $82 | $73.79 | 11.13% |
| 2023-11-20 | 17 | $92 | $60 | $80.625 | $73.79 | 9.26% |
| 2023-12-19 | 17 | $92 | $60 | $80.687 | $73.79 | 9.35% |
The Trend in the Analyst Price Target
IMCR's average price target has moved up $22.69 over the prior 26 months.
Over the past 47 weeks, IMCR's average upside potential has been 44.58%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-05-22 | 11 | 90 | 72 | 80.545 | 57.01 | 41.28% |
| 2023-05-22 | 12 | 90 | 72 | 80.545 | 57.01 | 41.28% |
| 2023-07-11 | 11 | 90 | 72 | 80.454 | 64.99 | 23.79% |
| 2023-07-20 | 12 | 90 | 67 | 79.333 | 63.01 | 25.91% |
| 2023-10-16 | 15 | 91 | 67 | 81.142 | 50.54 | 60.55% |
IMCR Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.18 | 15 | 1 | 1 | 0 | 0 | 17 |
The Trend in the Broker Recommendations
Over the past 19 months, IMCR's average broker recommendation rating worsened by 0.18.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for IMCR as an investment opportunity.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, IMMUNOCORE HOLDINGS PLC's upside potential (average analyst target price relative to current price) is greater than 637.18% of them.
- In terms of how IMMUNOCORE HOLDINGS PLC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than -797.12% of that group.
- In the context of Pharmaceutical Products stocks, IMMUNOCORE HOLDINGS PLC's average analyst price target is higher than 3500.21% of them.
- IMCR has a greater number of analysts covering the stock than 2629.77% of stocks in the mid market cap category.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to IMMUNOCORE HOLDINGS PLC are PCVX, RLAY, and ALVR.
View All Top Stocks by Price Target
What is the outlook for IMCR? Use POWR Ratings for clearer insight into price direction.